Background

Anna has degrees in Psychology, Public Health and is an admitted solicitor in both Australia and the United States. She worked as a research officer at the National Drug and Alcohol Research Centre at the University of New South Wales while completing her law degree. Once admitted to practice, she worked as a lawyer with the Human Rights team at Legal Aid New South Wales where she had a practice and was also seconded to develop and implement a pro bono legal program for refugees seeking asylum in Australia.

On leaving Legal Aid, she was the Deputy CEO and National Division Manager for the Australasian Society for HIV Medicine (ASHM) which implemented educational programs for medical practitioners around Australia in HIV, Viral hepatitis and Sexually Transmitted Infections as well as working with Federal and State governments to implement evidence-based policy.

Anna left ASHM to take up a fellowship position at the O’Neill Institute for National and Global Health Law at the Georgetown Law school in Washington, D.C. where she managed a range of projects and writing responsibilities.

Anna joined the Burnet as part of the Modelling and Biostatistics working group in 2017 and has been managing a portfolio of contracts and projects with that team ever since.

Positions

• 2019 – present: Senior Project Manager, Burnet Institute
• 2017 – 2019: Executive Business and Programs, Seconded to Optima Consortium for Decision Science
• 2015 – 2017: Fellow/ Associate O’Neill Institute for National and Global Health Law, Georgetown Law School
• 2013-2015: Deputy CEO & National Division Manager, Australasian Society for HIV Medicine
• 2011 – 2013: Solicitor, Legal Aid of New South Wales Human Rights Division
• 2007 – 2011: Research Officer, National Drug and Alcohol Research Centre, University of New South Wales

Qualifications

• 2010: Bachelor of Laws
• 2007: Master of International Public Health
• 2002: Bachelor of Arts, Psychology

Projects (6)

Current (6)

• 

  Decision science using Optima

• 

  Optima HIV Modelling

• 

  Optima Malaria Modelling

• 

  Optima Nutrition Modelling

• 

  Optima Tuberculosis (TB) Modelling

• 

  West Sepik Covid-19 Vaccination Advocacy Project

Publications (2)

2022 (1)

• Impacts of COVID-19-related service disruptions on TB incidence and deaths in Indonesia, Kyrgyzstan, Malawi, Mozambique, and Peru: Implications for national TB responses.
  Martin-Hughes R, Vu L, Cheikh N, Kelly SL, Fraser-Hurt N, Shubber Z, Manhic I, Mbendera K, Girma B, Pambudi I, Rıos J, Elmira A, Harimurti P, Hafez R, Nicolas Bayona Garcia J, Palmer T, Roberts A, Gorgens M, Wilson D
  PLoS Glob Pub Health. 2022 Mar; 2(3):e0000219

2021 (1)

• Optima TB: A tool to help optimally allocate tuberculosis spending.
  Goscé L, Abou Jaoude GJ, Kedziora DJ, Benedikt C, Hussain A, Jarvis S, Skrahina A, Klimuk D, Hurevich H, Zhao F, Fraser-Hurt N, Cheikh N, Gorgens M, Wilson DJ, Abeysuriya R, Martin-Hughes R, Kelly SL, Roberts A, Stuart RM, Palmer T, Panovska-Griffiths J, Kerr CC, Wilson DP, Haghparast-Bidgoli H, Skordis J, Abubakar I.
  PLoS Comput Biol. 2021 Sep; 17(9):e1009255